EMAIL DETAILS

Interesting. I can do a follow up call with him as he's an East Coast
prospect - LMK is that make sense.


Neil Callahan

Rosemont Seneca Technology Partners

Carnegie Hall Tower

152 West 57th, 47th Floor

New York, NY 10019

212-933-9965 (o)

917-945-9516 (m)

866-749-8879 (f)

www.rstp.com <http://www.rstp.com/>


Confidentiality Warning: This e-mail contains information intended only for
the use of the individual or entity named above. If the reader of this
e-mail is not the intended recipient or the employee or agent responsible
for delivering it to the intended recipient, any dissemination, publication
or copying of this e-mail is strictly prohibited. The sender does not accept
any responsibility for any loss, disruption or damage to your data or
computer system that may occur while using data contained in, or transmitted
with, this e-mail.If you have received this e-mail in error, please
immediately notify us by return e-mail. Thank you


From: Sebastian Momtazi [mailto:smomtazi@rosemontcapital.com]
Sent: Tuesday, May 13, 2014 11:45 AM
To: hbiden@rosemontseneca.com; Devon Archer; William Lee; Neil Callahan;
John DeLoche
Subject: Jim Graves/Whitford Holdings/Juneau Biosciences


Just received a call from Jim Graves who is with Whitford Holdings, just
outside of Philly. He read about Rosemont's investment in Counsyl. He works
with a molecular diagnostics firm -
http://www.juneaubiosciences.com/Juneau_Biosciences_Endometriosis_Research.h
tml - which designs tests for endometriosis, and has a go-to-market
strategy that doesn't require healthcare reimbursement initially. It has the
backing of a global pharma company with a stage 3 clinical trial.


Coincidentally, he says that he is former neighbor of VP Biden and knows
Hunter's aunt Valerie quite well. He would appreciate a call back: 302 367
6856


S